Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced positive topline full study results from the Phase 3 VISIONARY trial. VOYXACT ® ...

Bupropion conferred modest reductions in cancer-related fatigue compared with placebo, according to results of a randomized ...

Summary: Patients surviving severe traumatic brain injuries often enter states designated as Prolonged Disorders of Consciousness (PDoC) or Locked-In Syndrome (LIS). For decades, standard bedside ...

The wAIHA market landscape is undergoing a significant evolution after years of dependence on broad immunosuppressive ...

Findings provide mechanistic support for previously reported clinical outcomes of clinical reversal of platinum resistance/refractoriness from ...

Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.

Read Also: Evommune Stock Cools Off After Big Rally On Successful Eczema Trial Evommune, Inc. EVMN stock is trading lower on ...

NeuroSense Therapeutics Ltd.  ("NeuroSense"), a late-stage clinical biotechnology company focused on developing ...

Evommune, Inc. (NYSE: EVMN) (the "Company" or "Evommune"), a clinical-stage biotechnology company developing innovative ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with ...

Abstract: A novel weighed and summing bipolar photonic digital-to-analog converter (BPDAC) scheme employing optical differential phase shift keying modulation and balanced detection is proposed and ...

What Is It? Proprioception is the body’s ability to sense its position in space. This sensory process encompasses the awareness of different parts of the body, allowing for coordination and balance in ...